| | | | By Helen Branswell Adobe Annual boosters could become a default position, not one arrived at by careful scrutiny of the evidence, vaccine experts warn. Read More | By Andrew Joseph and Elizabeth Cooney David J. Phillip/AP The new findings, which go through February 2022, highlight just how widely the Omicron variant spread in the country. Read More | By Nicholas Florko Adobe A new right-to-try law, from the libertarian Goldwater Institute, is supposed to speed patients’ access to “n of 1” drugs. Read More | Sponsor content by MassBio What makes Massachusetts the state of possible? Massachusetts is home to the #1 life sciences cluster in the world, and the industry’s response to the Covid-19 pandemic has put us on the global stage. During its State of Possible Conference on May 5th, MassBio is bringing together today’s brightest minds to explore this ecosystem’s success and its future in a post-Covid world. Register today for a day of discussions featuring speakers Dr. Noubar Afeyan, Sekar Kathiresan M.D., Governor Deval Patrick, and more. | By Tino Delamerced Vanessa Leroy for STAT Among new recipients of a Ph.D. in the life sciences in 2020, 43% had committed to a job in industry — a 10-point jump from 2015. Read More | By Isabella Cueto Tim Boyle/Getty Images For most people without cardiovascular disease, taking low-dose aspirin may do more harm than good, a federal task force concluded. Read More | By Matthew Herper Pfizer The plan is to make antivirals available at more locations, add more test-to-treat centers, and start a new awareness campaign. Read More | By Helen Branswell YASUYOSHI CHIBA/AFP/Getty Images Advocates said the world would save $33 billion this century by eradicating polio, compared to the cost of continually trying to contain it. Read More | By Mario Aguilar Adobe Biofourmis raised $300 million as it looks to deliver on its promise to improve outcomes and cut costs with the help of technology. Read More | |
No comments